arrow
H

Huiping Shuai

The University of Hong Kong
H指数:29
被引数:4,315

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

YL1004 is a SARS-CoV-2 papain-like protease inhibitor with immunomodulatory and antiviral activity in mice

YL1004是一种SARS-CoV-2的木瓜蛋白酶样蛋白酶抑制剂,在小鼠中具有免疫调节和抗病毒活性

2026-01-260
OA
Author Correction: An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo

作者更正:一种口服可用的Mpro/TMPRSS2双特异性抑制剂,具有体内强效抗冠状病毒疗效

2025-12-150
OAAI
Pathogenicity, virological features, and immune evasion of SARS-CoV-2 JN.1-derived variants including JN.1.7, KP.2, KP.3, and KP.3.1.1

SARS-CoV-2 JN.1衍生变体 (包括JN.1.7、KP.2、KP.3和KP.3.1.1) 的致病性、病毒学特征和免疫逃避

2025-12-110
OAAI
An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo

一种口服可用的Mpro/TMPRSS2双特异性抑制剂,具有体内强效抗冠状病毒活性

2025-07-160
OA
Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3

SARS-CoV-2 BA.2.86/JN.1和EG.5.1/HK.3的谱系特异性致病性,免疫逃逸和病毒学特征

2024-10-091
OAAI
Type-II IFN inhibits SARS-CoV-2 replication in human lung epithelial cells and ex vivo human lung tissues through indoleamine 2,3-dioxygenase-mediated pathways
2024-02-192
OA
Divergent trajectory of replication and intrinsic pathogenicity of SARS-CoV-2 Omicron post-BA.2/5 subvariants in the upper and lower tract

SARS-CoV-2 Omicron post-BA.2/5亚型在上下道的复制和内在致病性的不同轨迹

2024-01-015
OAAI
The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5

优势SARS-CoV-2 Omicron亚系BA.1,BA.2和BA.5的病毒适应性和内在致病性

2023-09-0122
OAAI
Altered host protease determinants for SARS-CoV-2 Omicron
2023-01-2019
OAAI
Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2

导致SARS-CoV-2 omicron BA.1和BA.2进入偏好改变的尖峰突变

2022-09-2860
OAAI
Virological features and pathogenicity of SARS-CoV-2 Omicron BA.2
2022-09-0132
OAAI
Bacillus Calmette-Guerin-induced trained immunity protects against SARS-CoV-2 challenge in K18-hACE2 mice
2022-06-0837
OA
Emerging SARS-CoV-2 variants expand species tropism to murines
2021-11-01128
OAAI
Targeting highly pathogenic coronavirus-induced apoptosis reduces viral pathogenesis and disease severity
2021-06-1867
OAAI
Host and viral determinants for efficient SARS-CoV-2 infection of the human lung
2021-01-08120
OAAI